Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Pharmaceuticals Regulatory News (HEMO)

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes
Get Live Data
762.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 33.00 (4.424%)
Market Cap: £51.85m
HEMO Live PriceLast checked at - London Stock Exchange

Intraday Hemogenyx Pharmaceuticals Share Chart

Suspension

23 Dec 2015 12:45

RNS Number : 0583K
Official List
23 December 2015
 

NOTICE OF TEMPORARY SUSPENSION OF LISTING FROM THE OFFICIAL LIST

 

 

 

23/12/2015 12:45 PM

 

TEMPORARY SUSPENSION

 

Silver Falcon Plc

 

The Financial Conduct Authority ("the FCA") temporarily suspends the securities set out below from the Official List effective from 23/12/2015 12:45 PM at the request of the company pending an announcement:

 

Ordinary shares of GBP0.01 each

fully paid.

Standard Shares

(GB00BYX3WZ24) 

 

 

 

This notice has been issued by Listing Applications - 0207 066 8352.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOTFEIFEDFISEDE
Date   Source Headline
18th Nov 20204:41 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
18th Nov 20202:06 pmRNSSecond Price Monitoring Extn
18th Nov 20202:01 pmRNSPrice Monitoring Extension
18th Nov 202010:39 amRNSFinancing Facility of up to £60 Million
27th Oct 20207:00 amRNSCDX Development Agreement Further Extension
19th Oct 20207:00 amRNSPresentation at the American Society of Hematology
6th Oct 20207:00 amRNSSAFE-HEMO-CAR-T Effective against AML in vitro
30th Sep 20207:00 amRNSInterim Results for the period ended 30 June 2020
22nd Sep 202012:52 pmRNSFurther re. Grant of Options
10th Sep 20204:40 pmRNSSecond Price Monitoring Extn
10th Sep 20204:35 pmRNSPrice Monitoring Extension
26th Aug 20202:06 pmRNSSecond Price Monitoring Extn
26th Aug 20202:00 pmRNSPrice Monitoring Extension
25th Aug 20204:40 pmRNSSecond Price Monitoring Extn
25th Aug 20204:35 pmRNSPrice Monitoring Extension
21st Aug 20209:52 amRNSGrant of Options
14th Aug 20207:00 amRNSPresentations at Cancer Immunotherapy Symposia
11th Aug 20207:00 amRNSCAR-T Agreement with University of Pennsylvania
31st Jul 20207:00 amRNSBroker's Research Note
20th Jul 20204:40 pmRNSSecond Price Monitoring Extn
20th Jul 20204:35 pmRNSPrice Monitoring Extension
20th Jul 20202:05 pmRNSSecond Price Monitoring Extn
20th Jul 20202:00 pmRNSPrice Monitoring Extension
14th Jul 202011:00 amRNSPrice Monitoring Extension
14th Jul 20209:06 amRNSSecond Price Monitoring Extn
14th Jul 20209:00 amRNSPrice Monitoring Extension
13th Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20203:16 pmRNSGrant of Options
13th Jul 20203:13 pmRNSFurther re Development Agreement
10th Jul 20201:00 pmRNSUS Subsidiary Change of Name
6th Jul 20207:00 amRNSNew Corporate Video and Investor Webinar
1st Jul 202012:58 pmRNSTotal Voting Rights
30th Jun 20204:40 pmRNSSecond Price Monitoring Extn
30th Jun 20204:35 pmRNSPrice Monitoring Extension
30th Jun 20202:06 pmRNSSecond Price Monitoring Extn
30th Jun 20202:00 pmRNSPrice Monitoring Extension
30th Jun 202010:30 amRNSDirector/PDMR Shareholding
26th Jun 20202:06 pmRNSSecond Price Monitoring Extn
26th Jun 20202:00 pmRNSPrice Monitoring Extension
26th Jun 202011:05 amRNSSecond Price Monitoring Extn
26th Jun 202011:00 amRNSPrice Monitoring Extension
26th Jun 20209:05 amRNSSecond Price Monitoring Extn
26th Jun 20209:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSDevelopment Agmnt - Autoimmune Disease Treatments
24th Jun 20207:00 amRNSHemogenyx Chairman Receives Tang Prize
19th Jun 20202:06 pmRNSSecond Price Monitoring Extn
19th Jun 20202:01 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSCOVID-19 Project Update
9th Jun 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.